Mai Mohamed Abdelmoaty

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions”.

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions

Frontiers in Immunology(2021)10.3389/fimmu.2021.741502

N/A

1.4DataRank · unranked

47 citations

Pravin Yeapuri, Jatin Machhi, Katherine E. Olson, Farah Shahjin, Vikas Kumar +8 more

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease

EBioMedicine(2021)10.1016/j.ebiom.2021.103380

N/A

1.2DataRank · unranked

58 citations

Krista L. Namminga, Yaman Lu, Aaron Schwab, Mackenzie J. Thurston, Mai Mohamed Abdelmoaty +7 more

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers

Translational Neurodegeneration(2023)10.1186/s40035-023-00361-1

N/A

0.759DataRank · unranked

33 citations

Mai Mohamed Abdelmoaty, Krista L. Namminga, Yaman Lu, Helen Obaro, Pamela M. Santamaria +3 more

Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.07.449660

N/A

0DataRank · unranked

6 citations

Pravin Yeapuri, Jatin Machhi, Katherine E. Olson, Farah Shahjin, You Zhou +7 more

Development of an extended half-life GM-CSF fusion protein for Parkinson's disease

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.06.024

N/A

0DataRank · unranked

38 citations

Katherine E. Olson, Yaman Lu, Mai Mohamed Abdelmoaty, Krista L. Namminga, Milica Marković +4 more

Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC

Non-Coding RNA(2022)10.3390/ncrna8010008

N/A

0DataRank · unranked

5 citations

Mai Mohamed Abdelmoaty, Stephen Curran, Shetty Ravi Dyavar, Devendra Kumar, Yazen Alnouti +5 more

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Molecular Neurodegeneration(2023)10.1186/s13024-023-00692-7

N/A

0DataRank · unranked

76 citations

Jatin Machhi, Yaman Lu, Mai Mohamed Abdelmoaty, Rana Kadry, Milankumar Patel +8 more

Clinical biomarkers for Lewy body diseases

Cell & Bioscience(2023)10.1186/s13578-023-01152-x

N/A

0DataRank · unranked

16 citations

Eugene Y. C. Lu, Rana Kadry, Emma G. Foster, Shaurav Bhattarai, R. Lee Mosley +2 more

CD4+ effector T cells accelerate Alzheimer’s disease in mice

Journal of Neuroinflammation(2021)10.1186/s12974-021-02308-7

N/A

0DataRank · unranked

154 citations

Pravin Yeapuri, Yaman Lu, Emma G. Foster, Rupesh V. Chikhale, Jonathan Herskovitz +15 more

Immune senescence in aged APP/PS1 mice

NeuroImmune Pharmacology and Therapeutics(2023)10.1515/nipt-2023-0015

N/A

0DataRank · unranked

10 citations

Pravin Yeapuri, Jatin Machhi, Yaman Lu, Krista L. Namminga, Rana Kadry +5 more

A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention

Journal of Neuroimmune Pharmacology(2021)10.1007/s11481-020-09981-0

N/A

0DataRank · unranked

49 citations

Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen +22 more

Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer

Nanomedicine Nanotechnology Biology and Medicine(2021)10.1016/j.nano.2021.102363

N/A

0DataRank · unranked

6 citations

Mai Mohamed Abdelmoaty, Vishakha V. Ambardekar, Stephen Curran, Shetty Ravi Dyavar, Lora L. Arnold +7 more